These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31939034)

  • 21. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
    Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
    Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients.
    Conci S; Ruzzenente A; Simbolo M; Bagante F; Rusev B; Isa G; Lawlor RT; Pedrazzani C; Iacono C; Guglielmi A; Scarpa A
    Updates Surg; 2020 Mar; 72(1):119-128. PubMed ID: 32020551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative and Long-Term Outcomes of Laparoscopic Versus Open Lymphadenectomy for Biliary Tumors: A Propensity-Score-Based, Case-Matched Analysis.
    Ratti F; Fiorentini G; Cipriani F; Paganelli M; Catena M; Aldrighetti L
    Ann Surg Oncol; 2019 Feb; 26(2):564-575. PubMed ID: 30276646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections.
    Takahashi Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Nimura Y; Nagino M
    Ann Surg; 2015 Jul; 262(1):121-9. PubMed ID: 25405563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis.
    Hong L; Huang YX; Zhuang QY; Zhang XQ; Tang LR; Du KX; Lin XY; Zheng BH; Cai SL; Wu JX; Li JL
    Radiat Oncol; 2018 Sep; 13(1):171. PubMed ID: 30201005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.
    McNamara MG; Templeton AJ; Maganti M; Walter T; Horgan AM; McKeever L; Min T; Amir E; Knox JJ
    Eur J Cancer; 2014 Jun; 50(9):1581-9. PubMed ID: 24630393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
    Agopian VG; Harlander-Locke MP; Ruiz RM; Klintmalm GB; Senguttuvan S; Florman SS; Haydel B; Hoteit M; Levine MH; Lee DD; Taner CB; Verna EC; Halazun KJ; Abdelmessih R; Tevar AD; Humar A; Aucejo F; Chapman WC; Vachharajani N; Nguyen MH; Melcher ML; Nydam TL; Mobley C; Ghobrial RM; Amundsen B; Markmann JF; Langnas AN; Carney CA; Berumen J; Hemming AW; Sudan DL; Hong JC; Kim J; Zimmerman MA; Rana A; Kueht ML; Jones CM; Fishbein TM; Busuttil RW
    Ann Surg; 2017 Sep; 266(3):525-535. PubMed ID: 28654545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer.
    Ulusakarya A; Karaboué A; Ciacio O; Pittau G; Haydar M; Biondani P; Gumus Y; Chebib A; Almohamad W; Innominato PF
    BMC Cancer; 2020 Jun; 20(1):515. PubMed ID: 32493242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Resection for Pulmonary Metastasis from Pancreatic and Biliary Tract Cancer.
    Tagawa T; Ito K; Fukuzawa K; Okamoto T; Yoshimura A; Kawasaki T; Masuda T; Iwaki K; Terashi T; Okamoto M; Shiromizu A; Motohiro A; Maehara Y
    Anticancer Res; 2017 Mar; 37(3):1413-1416. PubMed ID: 28314312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
    Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
    World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
    Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
    Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative External Irradiation of Patients with Primary Biliary Tract Cancer: A Multicenter Retrospective Study.
    Hayashi K; Isohashi F; Ogawa K; Oikawa H; Onishi H; Ito Y; Takemoto M; Karasawa K; Imai M; Kosaka Y; Yamazaki H; Yoshioka Y; Nemoto K; Nishimura Y;
    Anticancer Res; 2015 Nov; 35(11):6231-7. PubMed ID: 26504056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
    McNamara MG; Aneja P; Le LW; Horgan AM; McKeever E; Knox JJ
    Hepatogastroenterology; 2015 May; 62(139):564-9. PubMed ID: 26897929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy.
    Takahara N; Nakai Y; Saito K; Sasaki T; Suzuki Y; Inokuma A; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Saito T; Hamada T; Mizuno S; Kogure H; Tada M; Isayama H; Koike K
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1828-1835. PubMed ID: 32267557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
    Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study.
    Nie C; Lv H; Xing Y; Chen B; Xu W; Wang J; Chen X
    BMC Cancer; 2021 Feb; 21(1):189. PubMed ID: 33622272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-glycan signatures identified in the serum from biliary tract cancer patients: Association with clinical diagnosis and prognosis.
    Huang C; Qiu Z; Wang M; Ji J; Xiao X; Wang Y; Xu X; Gao Z; Gao C
    J Hepatobiliary Pancreat Sci; 2024 Aug; 31(8):537-548. PubMed ID: 38824438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Older adults with biliary tract cancer: treatment and prognosis.
    Lee BS; Hwang JH; Lee SH; Jang SE; Ahn DW; Hwang DW; Cho JY; Yoon YS; Han HS; Ahn S
    J Am Geriatr Soc; 2012 Oct; 60(10):1862-71. PubMed ID: 23035728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.